Authors:
PLIT ML
THERON AJ
FICKL H
VANRENSBURG CEJ
PENDEL S
ANDERSON R
Citation: Ml. Plit et al., INFLUENCE OF ANTIMICROBIAL CHEMOTHERAPY AND SMOKING STATUS ON THE PLASMA-CONCENTRATIONS OF VITAMIN-C, VITAMIN-E, BETA-CAROTENE, ACUTE-PHASEREACTANTS, IRON AND LIPID PEROXIDES IN PATIENTS WITH PULMONARY TUBERCULOSIS, The international journal of tuberculosis and lung disease, 2(7), 1998, pp. 590-596
Authors:
RUFF P
CHASEN MR
LONG JEH
VANRENSBURG CEJ
Citation: P. Ruff et al., A PHASE-II STUDY OF ORAL CLOFAZIMINE IN UNRESECTABLE AND METASTATIC HEPATOCELLULAR-CARCINOMA, Annals of oncology, 9(2), 1998, pp. 217-219
Authors:
PLIT ML
ANDERSON R
VANRENSBURG CEJ
PAGESHIPP L
BLOTT JA
FRESEN JL
FELDMAN C
Citation: Ml. Plit et al., INFLUENCE OF ANTIMICROBIAL CHEMOTHERAPY ON SPIROMETRIC PARAMETERS ANDPRO-INFLAMMATORY INDEXES IN SEVERE PULMONARY TUBERCULOSIS, The European respiratory journal, 12(2), 1998, pp. 351-356
Citation: Cej. Vanrensburg et al., ALPHA-TOCOPHEROL ANTAGONIZES THE MULTIDRUG-RESISTANCE-REVERSAL ACTIVITY OF CYCLOSPORINE-A, VERAPAMIL, GF120918, CLOFAZIMINE AND B669, Cancer letters, 127(1-2), 1998, pp. 107-112
Citation: G. Caldwell et al., CYTOTOXICITY OF SELECTED WATER-SOLUBLE POLYMER-CIS-DIAMINEDICHLOROPLATINUM(II) CONJUGATES AGAINST THE HUMAN HELA CANCER CELL-LINE, Journal of inorganic and organometallic polymers, 7(4), 1997, pp. 217-231
Citation: Cej. Vanrensburg et al., RIMINOPHENAZINE COMPOUNDS - PHARMACOLOGY AND ANTINEOPLASTIC POTENTIAL, Critical reviews in oncology/hematology, 25(1), 1997, pp. 55-67
Citation: Cej. Vanrensburg et al., ALPHA-TOCOPHEROL (AT) ANTAGONIZES THE MULTIDRUG-RESISTANCE REVERSAL ACTIVITY OF CYCLOSPORINE A(2) VERAPAMIL, CLOFAZIMINE AND B669, European journal of cancer, 33, 1997, pp. 777-777
Citation: G. Joone et Cej. Vanrensburg, CLOFAZIMINE AND B4121 SENSITIZE AN INTRINSICALLY RESISTANT HUMAN COLON-CANCER CELL-LINE TO PACLITAXEL AND TAXOTERE, European journal of cancer, 33, 1997, pp. 804-804
Authors:
VANRENSBURG CEJ
ANDERSON R
JOONE G
MYER MS
OSULLIVAN JF
Citation: Cej. Vanrensburg et al., NOVEL TETRAMETHYLPIPERIDINE-SUBSTITUTED PHENAZINES ARE POTENT INHIBITORS OF P-GLYCOPROTEIN ACTIVITY IN A MULTIDRUG-RESISTANT CANCER CELL-LINE, Anti-cancer drugs, 8(7), 1997, pp. 708-713
Citation: S. Vanniekerk et al., A TIME-KILL STUDY TO EVALUATE THE IN-VITRO ACTIVITY OF CLOFAZIMINE INCOMBINATION WITH CEFOTAXIME AGAINST A PENICILLIN-RESISTANT AND CEFOTAXIME-RESISTANT STRAIN OF STREPTOCOCCUS-PNEUMONIAE, Journal of antimicrobial chemotherapy, 40(4), 1997, pp. 602-604
Authors:
SCHULZE DLC
MAKGATHO EM
COETZER TL
LOUW AI
VANRENSBURG CEJ
VISSER L
Citation: Dlc. Schulze et al., DEVELOPMENT AND APPLICATION OF A MODIFIED FLOW CYTOMETRIC PROCEDURE FOR RAPID IN-VITRO QUANTITATION OF MALARIA PARASITEMIA, South African journal of science, 93(4), 1997, pp. 156-158
Citation: Cej. Vanrensburg et al., THE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 INHIBITS THE PROLIFERATION OF INTRINSICALLY MULTIDRUG-RESISTANT CARCINOMA CELL-LINES (VOL 3, PG 103, 1996), Oncology Reports, 3(2), 1996, pp. 413-413
Citation: Cej. Vanrensburg et al., THE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 INHIBIT THE PROLIFERATION OF INTRINSICALLY MULTIDRUG-RESISTANT CARCINOMA CELL-LINES, Oncology Reports, 3(1), 1996, pp. 103-106
Authors:
DEBRUYN EE
STEEL HC
VANRENSBURG CEJ
ANDERSON R
Citation: Ee. Debruyn et al., THE RIMINOPHENAZINES, CLOFAZIMINE AND B669, INHIBIT POTASSIUM-TRANSPORT IN GRAM-POSITIVE BACTERIA BY A LYSOPHOSPHOLIPID-DEPENDENT MECHANISM, Journal of antimicrobial chemotherapy, 38(3), 1996, pp. 349-362
Citation: Ms. Myer et Cej. Vanrensburg, CHEMOSENSITIZING INTERACTIONS OF CLOFAZIMINE AND B669 WITH HUMAN K562ERYTHROLEUKEMIA-CELLS WITH VARYING LEVELS OF EXPRESSION OF P-GLYCOPROTEIN, Cancer letters, 99(1), 1996, pp. 73-78
Citation: Ms. Myer et Cej. Vanrensburg, CHEMOSENSITIZING INTERACTIONS OF CLOFAZIMINE AND B669 WITH HUMAN K562ERYTHROLEUKEMIA-CELLS WITH VARYING LEVELS OF EXPRESSION OF P-GLYCOPROTEIN (VOL 99, PG 73, 1996), Cancer letters, 101(2), 1996, pp. 263-263
Authors:
DURANDT C
VANRENSBURG CEJ
OSULLIVAN JF
ANDERSON R
Citation: C. Durandt et al., NOVEL RIMINOPHENAZINE COMPOUNDS WITH IMPROVED ANTITUMOR PROPERTIES, South African journal of science, 92(5), 1996, pp. 257-259
Authors:
PRINSLOO Y
VANRENSBURG CEJ
VANDERWALT R
ANDERSON R
Citation: Y. Prinsloo et al., AUGMENTATIVE INHIBITION OF LYMPHOCYTE-PROLIFERATION BY CYCLOSPORINE-ACOMBINED WITH THE RIMINOPHENAZINE COMPOUNDS CLOFAZIMINE AND B669, Inflammation research, 44(9), 1995, pp. 379-385
Citation: Cej. Vanrensburg et al., AN IN-VITRO INVESTIGATION OF THE BIOACTIVITIES OF CIPROFLOXACIN AND THE NEW FLUOROQUINOLONE AGENTS CLINAFLOXACIN (CL-960) AND PD-131628 AGAINST MYCOBACTERIUM-TUBERCULOSIS IN HUMAN MACROPHAGES, Chemotherapy, 41(4), 1995, pp. 234-238
Citation: Cej. Vanrensburg et al., THE ANTIPROLIFERATIVE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 PROMOTE LYSOPHOSPHOLIPID-MEDIATED INHIBITION OF NA-ADENOSINE TRIPHOSPHATASE-ACTIVITY IN CANCER CELL-LINES IN-VITRO(, K+), International journal of oncology, 4(5), 1994, pp. 1115-1119
Citation: Cej. Vanrensburg et A. Vanstraten, AN IN-VITRO INVESTIGATION OF THE SUSCEPTIBILITY OF ENTEROCOCCUS-FAECALIS TO CLOFAZIMINE AND B669, Journal of antimicrobial chemotherapy, 33(2), 1994, pp. 356-358
Authors:
VANRENSBURG CEJ
ANDERSON R
MYER MS
JOONE GK
OSULLIVAN JF
Citation: Cej. Vanrensburg et al., THE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 REVERSE ACQUIRED MULTIDRUG-RESISTANCE IN A HUMAN LUNG-CANCER CELL-LINE, Cancer letters, 85(1), 1994, pp. 59-63
Citation: R. Anderson et al., ALPHA-TOCOPHEROL PREVENTS CYCLOSPORINE A-MEDIATED ACTIVATION OF PHOSPHOLIPASE A(2) AND INHIBITION OF NA-ADENOSINE TRIPHOSPHATASE-ACTIVITY IN CULTURED HAMSTER RENAL TUBULAR CELLS(,K+), Toxicology and applied pharmacology, 125(2), 1994, pp. 176-183
Authors:
VANRENSBURG CEJ
DURANDT C
GARLINSKI PJ
OSULLIVAN JF
Citation: Cej. Vanrensburg et al., EVALUATION OF THE ANTINEOPLASTIC ACTIVITIES OF THE RIMINOPHENAZINE AGENTS CLOFAZIMINE AND B669 IN TUMOR-BEARING RATS AND MICE, International journal of oncology, 3(5), 1993, pp. 1011-1013
Citation: Am. Vanstaden et al., VITAMIN-E PROTECTS MONONUCLEAR LEUKOCYTE DNA AGAINST DAMAGE MEDIATED BY PHAGOCYTE-DERIVED OXIDANTS, MUTATION RESEARCH, 288(2), 1993, pp. 257-262